# Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study

> **NCT02266992** · PHASE2 · COMPLETED · sponsor: **Sheffield Teaching Hospitals NHS Foundation Trust** · enrollment: 28 (actual)

## Conditions studied

- Acquired Immune Deficiency Syndrome Virus

## Interventions

- **BIOLOGICAL:** Live attenuated Vaccine- Fluenz Tretra

## Key facts

- **NCT ID:** NCT02266992
- **Lead sponsor:** Sheffield Teaching Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2016-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02266992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02266992, "Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02266992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*